Phototoxicity of herbal plants and herbal products

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 31, Issue 3, 2013, Pages 213-255

  Fu, Peter P ^a   Xia, Qingsu ^a   Zhao, Yuewei ^a   Wang, Shuguang ^a   Yu, Hongtao ^b   Chiang, Hsiu Mei ^c  

^a National Center for Toxicological Research   (United States)

^b JACKSON STATE UNIVERSITY   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

herbal; mechanism of action; photocarcinogenicity; photogenotoxicity; phototoxicity; phytochemicals; PUVA therapy

Indexed keywords

HERBAL; MECHANISM OF ACTION; PHOTO-TOXICITY; PHOTOCARCINOGENICITY; PHOTOGENOTOXICITY; PHYTOCHEMICALS; PUVA THERAPY;

MUTAGENESIS;

ONCOLOGY;

5 METHYLANGELICIN; 5,7 DIMETHOXYCOUMARIN; ANGELICIN; ANGENOMALIN; ATHAMANTIN; AZULENE; BERBERINE; BERGAMOTTIN; BERGAPTEN; BERGAPTOL; CELL DNA; COSMETIC; COUMARIN; COUMARIN DERIVATIVE; FUROCOUMARIN; FUROCOUMARIN DERIVATIVE; GUAIAZULENE; HERBACEOUS AGENT; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; ISOPIMPINELLIN; KAVA; METHOXSALEN; PENTOSALEN; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PSORALEN; PYRROLIZIDINE ALKALOID; UMBELLIFERONE; UNCLASSIFIED DRUG;

AGING; ARTICLE; BRASSICACEAE; CARCINOGENESIS; CHEMICAL COMPOSITION; CYTOTOXICITY; DIET SUPPLEMENTATION; DNA ADDUCT; DNA DAMAGE; FABACEAE; FOOD; GENOTOXICITY; HERACLEUM; HERBAL MEDICINE; HUMAN; LIPID PEROXIDATION; LIVER INJURY; MAHONIA; MORACEAE; NONHUMAN; PARSLEY; PARSNIP; PEPPER; PHOTOACTIVATION; PHOTOCARCINOGENESIS; PHOTOCYTOTOXICITY; PHOTODEGRADATION; PHOTOGENOTOXICITY; PHOTOTOXICITY; PHYTOCHEMISTRY; PLANT; PUVA; RANUNCULACEAE; RHUBARB; RUTACEAE; SKIN CANCER; UNSCHEDULED DNA SYNTHESIS;

ANIMALS; DERMATITIS, PHOTOTOXIC; HUMANS; MICE; PHOTOSENSITIZING AGENTS; PHYTOCHEMICALS; PLANTS; RATS; TOXICITY TESTS;

EID: 84884562983     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590501.2013.824206     Document Type: Article

References (290)

1. Mukhtar H. Skin Cancer: Mechanisms and Human Relevance. Boca Raton, FL: CRC Press; 1995.
2. Bark KM, Heo EP, Han KD, et al. Evaluation of the phototoxic potential of plants used in oriental medicine. J Ethnopharm. 2010; 127:11-18.
3. Lim HW. Abnormal responses to ultraviolet radiation: photosensitivity induced by exogenous agents. In: Freedberg IM, Eisen AZ, Wolff K, Austin AF, Goldsmith LA, Katz SI (Eds.), Dermatology in General Medicine. New York: McGraw-Hill; 2003:1298-1307.
4. Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). New Engl J Med. 1997; 336:1041-1045.
5. Epstein JH. Chemical phototoxicity in humans. J Natl Cancer Inst. 1982; 69:265-268.
6. Fuchs J, Thiele J. The role of oxygen in cutaneous photodynamic therapy. Free Radical Biol Med. 1998; 24:835-847.
7. Hönigsmann H, Szeimies R-M, Knober R, Fitzpatrick TB, Pathak MA, Wolff K. Photochemotherapy and Photodynamic Therapy. Freedberg: IM; 2003.
8. Mantle D, Gok MA, Lennard TW. Adverse and beneficial effects of plant extracts on skin and skin disorders. Adverse Drug React Toxicol Rev. 2001; 20:89-103.
9. Klaber R. Dermatitis artefacta. Proc R Soc Med. 1942; 36:45.
10. Reuter NP, Bower M, Scoggins CR, Martin RC, McMasters KM, Chagpar AB. The lower incidence of melanoma in women may be related to increased preventative behaviors. Am J Surg. 2010; 200:765-769.
11. Schmidt J. Phytophotodermatitis. Dermatol Nursing/Dermatol Nurses' Assoc. 2007; 19:486.
12. Zurer PS, Hanson D. Chemistry puts herbal supplements to the test. Chem & Eng News. 2004; 82:16.
13. Fu PP, Chiang H-M, Xia Q, et al. Quality assurance and safety of herbal dietary supplements. J Environ Sci Health Part C. 2009; 27:91-119.
14. Chiang H-M, Yin J-J, Xia Q, et al. Photoirradiation of azulene and guaiazulene-Formation of reactive oxygen species and induction of lipid peroxidation. J Photochem Photobiol A: Chemistry. 2010; 211:123-128.
15. Dong S, Fu PP, Hwang H-M, Yu H. Effects of histidine on light-induced DNA single strand cleavage by selected polycyclic aromatic hydrocarbons. Polycycl Arom Compd. 2002; 22:451-458.
16. Dong S, Fu PP, Shirsat RN, Hwang H-M, Leszczynski J, Yu H. UVA lightinduced DNA cleavage by isomeric methylbenz[a]anthracenes. Chem Res Toxicol. 2002; 15:400-409.
17. Dong S, Wang S, Stewart G, Hwang H-M, Fu PP, Yu H. Effect of solvents and biologically relevant ions on the light-induced DNA cleavage by polycyclic aromatic hydrocarbons. Int J Mol Sci. 2002; 3:934-944.
18. Fu PP, Xia Q, Sun X, Yu H. Phototoxicity and environmental transformation of polycyclic aromatic hydrocarbons (PAHs)-light-induced reactive oxygen species, lipid peroxidation, and DNA damage. J Environ Sci Health, Part C. 2012; 30: 1-41.
19. Herreno-Saenz D, Xia Q, Chiu LT, Fu PP. UVA photoirradiation of halogenatedpolycyclic aromatic hydrocarbons leading to induction of lipid peroxidation. Int J Environ Res Public Health. 2006; 3:191-195.
20. Herreno-Saenz D, Xia Q, Fu PP. UVA Photoirradiation of methylated benzo [a] pyrene and benzo [e] pyrene leading to induction of lipid peroxidation. Int J Environ Res Public Health. 2007; 4:153-157.
21. Kagan J, Wang TP, Benight AS, Tuveson RW, Wang G-R, Fu PP. The phototoxicity of nitro polycyclic aromatic hydrocarbons of environmental importance. Chemosphere. 1990; 20:453-466.
22. Stewart G, Jiao Y, Valente EJ, et al. Photochemical reaction of 9-nitrosubstituted anthracene-like molecules 9-methyl-10-nitroanthracene and 12-methyl-7-nitrobenz [a] anthracene. J Photochem Photobiol A: Chemistry. 2009; 201:39-44.
23. Wang L, Yan J, Fu PP, Parekh KA, Yu H. Photomutagenicity of cosmetic ingredient chemicals azulene and guaiazulene. Mutat Res-Fund Mol M. 2003; 530: 19-26.
24. Wang L, Yan J, Wang S, et al. Phototoxicity and DNA damage induced by the cosmetic ingredient chemical azulene in human Jurkat T-cells. Mutat Res/Gen Tox Env Mut. 2004; 562:143n150.
25. White GL, Fu PP, Heflich RH. Effect of nitro substitution on the light-mediated mutagenicity of polycyclic aromatic hydrocarbons in Salmonella typhimurium TA 98. Mutat Res. 1985; 144:1-7.
26. Xia Q, Chou MW, Yin JJ, Howard PC, Yu H, Fu PP. Photoirradiation of representative polycyclic aromatic hydrocarbons and twelve isomeric methylbenz [a] anthracene with UVA light: formation of lipid peroxidation. Toxicol Ind Health. 2006; 22:147-156.
27. Xia Q, Yin J-J, Zhao Y, et al. UVA Photoirradiation of nitro-polycyclic aromatic hydrocarbons-induction of reactive oxygen species and formation of lipid peroxides. Int J Environ Res Pub Health. 2013; 10:1062-1084.
28. Yan J, Wang L, Fu PP, Yu H. Photomutagenicity of sixteen polycyclic aromatic hydrocarbons in the US EPA priority pollutant list. Mutat Res. 2004; 557:99-108.
29. Yu H. Environmental carcinogenic polycyclic aromatic hydrocarbons: photochemistry and phototoxicity. J Environ Sci Health, Part C. 2002; C20:149-183.
30. Yu H, Xia Q, Yan J, et al. Photoirradiation of polycyclic aromatic hydrocarbons with UVA light-a pathway leading to the generation of reactive oxygen species, lipid peroxidation, and DNA damage. Int J Environ Res Public Health. 2006; 3:348-354.
31. Yu H, Yan J, Jiao Y, Fu PP. Photochemical reaction of 7, 12-dimethylbenz [a] anthracene (DMBA) and formation of DNA covalent adducts. Int Environ Res Public Health. 2005; 2:114-122.
32. Zeng K, Hwang H-M, Fu PP, Yu H. Identification of 1-hydroxypyrene photoproducts and study of the effect by humic substances on its photolysis. Polycycl Arom Compd. 2002; 22:459-467.
33. Zhao Y, Xia Q, Yin J-J, Yu H, Fu PP. Photoirradiation of polycyclic aromatic hydrocarbon diones by UVA light leading to lipid peroxidation. Chemosphere. 2011; 85:83-91.
34. Xia Q, Chiang H-M, Yin J-J, et al. UVA photoirradiation of benzo [a] pyrene metabolites: induction of cytotoxicity, reactive oxygen species, and lipid peroxidation. Toxicol Ind Health. 2013; 29:1-13.
35. Fu PP, Xia Q, Chou MW, Lin G. Detection, hepatotoxicity, and tumorigenicity of pyrrolizidine alkaloids in Chinese herbal plants and herbal dietary supplements. J Food Drug Anal. 2007; 15:400-415.
36. Fu PP, Xia Q, Lin G, Chou MW. Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev. 2004; 36:1-55.
37. Zhao Y, Xia Q, Yin JJ, Lin G, Fu PP. Photoirradiation of dehydropyrrolizidine alkaloids. Formation of reactive oxygen species and induction of lipid peroxidation. Toxicol Lett. 2011; 205:302-309.
38. Xia Q, Chiang H-M, Zhou Y-T, et al. Phototoxicity of kava-formation of reactive oxygen species leading to lipid peroxidation and DNA damage. Am J Chinese Med. 2012; 40:1271-1288.
39. Fu PP, Xia Q, Guo L, Yu H, Chan P-C. Toxicity of kava kava. J Environ Sci Health Part C. 2008; 26:89-112.
40. Cherng S-H, Xia Q, Blankenship LR, et al. Photodecomposition of retinyl palmitate in ethanol by UVA light formation of photodecomposition products, reactive oxygen species, and lipid peroxides. Chem Res Toxicol. 2005; 18:129-138.
41. Fu PP, Cheng SH, Coop L, et al. Photoreaction, phototoxicity, and photocarcinogenicity of retinoids. J Environ Sci Health, Part C. 2003; 21:165-197.
42. Fu PP, Howard PC, Culp SJ, et al. Do topically applied skin creams containing retinyl palmitate affect the photocarcinogenecity of simulated solar light? J Food Drug Anal. 2002; 10:262-268.
43. Fu PP, Xia Q, Boudreau MD, Howard PC, Tolleson WH, Wamer WG. Physiological role of retinyl palmitate in the skin. Vitamins & Hormones. 2007; 75: 223-256.
44. Fu PP, Xia Q, Yin JJ, et al. Photodecomposition of vitamin a and photobiological implications for the skin. Photochem Photobiol. 2007; 83:409-424.
45. Mei N, Hu J, Xia Q, Fu PP, Moore MM, Chen T. Cytotoxicity and mutagenicity of retinol with ultraviolet A irradiation in mouse lymphoma cells. Toxicol In Vitro. 2010; 24:439-444.
46. Mei N, Xia Q, Chen L, Moore MM, Chen T, Fu PP. Photomutagenicity of anhydroretinol and 5, 6-epoxyretinyl palmitate in mouse lymphoma cells. Chem Res Toxicol. 2006; 9:1435-1440.
47. Mei N, Xia Q, Chen L, Moore MM, Fu PP, Chen T. Photomutagenicity of retinyl palmitate by ultraviolet A irradiation in mouse lymphoma cells. Toxicol Sci. 2005; 88:142-149.
48. Tolleson WH, Cherng S-H, Xia Q, et al. Photodecomposition and phototoxicity of natural retinoids. Int J Environ Res Pub Health. 2005; 2:147-155.
49. Xia Q, Yin JJ, Cherng S-H, et al. UVA photoirradiation of retinyl palmitate-Formation of singlet oxygen and superoxide, and their role in induction of lipid peroxidation. Toxicol Lett. 2006; 163:30-43.
50. Xia Q, Yin JJ, Wamer WG, et al. Photoirradiation of retinyl palmitate in ethanol with ultraviolet light-formation of photodecomposition products, reactive oxygen species, and lipid peroxides. Int J Environ Res Pub Health. 2006; 3: 185-190.
51. Yan J, Xia Q, Cherng S-H, et al. Photo-induced DNA damage and photocytotoxicity of retinyl palmitate and its photodecomposition products. Toxicol Ind Health. 2005; 21:167-175.
52. Yan J, Xia Q, Wamer WG, et al. Levels of retinyl palmitate and retinol in the skin of SKH-1 mice topically treated with retinyl palmitate and concomitant exposure to simulated solar light for thirteen weeks. Toxicol Ind Health. 2007; 23: 581-589.
53. Yin JJ, Xia Q, Cherng SH, et al. UVA photoirradiation of oxygenated benz[a]anthracene and 3-methylcholanthene-generation of singlet oxygen and induction of lipid peroxidation. Int J Environ Res Pub Health. 2008; 5:26-31.
54. Yin JJ, Xia Q, Fu PP. UVA photoirradiation of anhydroretinol-formation of singlet oxygen and superoxide. Toxicol Ind Health. 2007; 23:625-631.
55. Xia Q, Boudreau MD, Zhou YT, Yin JJ, Fu PP. UVB Photoirradiation of Aloe vera-formation of free radicals, singlet oxygen, superoxide, and induction of lipid peroxidation. J Food Drug Anal. 2011; 19:396-402.
56. Xia Q, Yin JJ, Fu PP, Boudreau MD. Photo-irradiation of aloe vera by UVAformation of free radicals, singlet oxygen, superoxide, and induction of lipid peroxidation. Toxicol Lett. 2007; 168:165-175.
57. Chiang H-m, Xia Q, Zou X, et al. Nanoscale ZnO induces cytotoxicity and DNA damage in human cell lines and rat primary neuronal cells. J Nanosci Nanotech. 2012; 12:2126-2135.
58. Ray PC, Yu H, Fu PP. Toxicity and environmental risks of nanomaterials: challenges and future needs. J Environ Sci Health, Part C. 2009; 27:1-35.
59. Ray PC, Yu H, Fu PP. Nanogold-based sensing of environmental toxins: excitement and challenges. J Environ Sci Health, Part C. 2011; 29:52-89.
60. Wang C-C, Wang S, Xia Q, et al. Phototoxicity of zinc oxide nanoparticles in Ha-CaT keratinocytes-generation of oxidative DNA damage during UVA and visible light irradiation. J Nanosci Nanotech. 2013; 13:3880-3888.
61. Yin J-J, Liu J, Ehrenshaft M, et al. Phototoxicity of nano titanium dioxides in HaCaT keratinocytes-generation of reactive oxygen species and cell damage. Toxicol Appl Pharmacol. 2012; 263:81-88.
62. Lovell CR. Phytodermatoses. Harper's Textbook of Pediatric Dermatology, Volume 1, 2, Third Edition. Wiley-Blackwell, West Sussex, UK 2006; 45:41-45.11.
63. Gawkrodger DJ, Savin JA. Phytophotodermatitis due to common rue (Ruta graveolens). Contact Dermatitis. 1983; 9:224.
64. Ortiz-Frutos FJ, Sanchez B, Garcia B, Iglesias L, Sanchez-Mata D. Photocontact dermatitis from rue (Ruta montana L.). Contact Dermatitis. 1995; 33:284.
65. Menichini F, Tundis R, Loizzo MR, BonesiM, Provenzano E, de Cindio B. In vitro photo-induced cytotoxic activity of Citrus bergamia and C. medica L. cv. Diamante peel essential oils and identified active coumarins. Pharmacol Biol. 2010; 48:1059-1065.
66. Messer A, Raquet N, Lohr C, Schrenk D. Major furocoumarins in grapefruit juice II: phototoxicity, photogenotoxicity, and inhibitory potency vs. cytochrome P450 3A4 activity. Food Chem Toxicol. 2012; 50:756-760.
67. Derraik JG, Rademaker M. Phytophotodermatitis caused by contact with a fig tree (Ficus carica). N Z Med J. 2007; 120:U2720.
68. Derraik JG, Rademaker M. Phytophotodermatitis caused by contact with a fig tree (Ficus carica). N Z Med J. 2007; 120:U2658.
69. Rademaker M, Derraik JG. Phytophotodermatitis caused by Ficus pumila. Contact Dermatitis. 2012; 67:53-56.
70. Zaynoun ST, Aftimos BG, Abi Ali L, Tenekjian KK, Khalidi U, Kurban AK. Ficus carica; isolation and quantification of the photoactive components. Contact Dermatitis. 1984; 11:21-25.
71. Jackson IM, Bolaffi JL, Guillemin R. Presence of immunoreactive beta-endorphin and encephalin-like material in the retina and other tissues of the frog, Rana pipiens. Gen Comp Endocr. 1980; 42:505-508.
72. Ljunggren B. Psoralen photoallergy caused by plant contact. Contact Dermatitis. 1977; 3:85-90.
73. Pathak MA, Daniels F, Jr., Fitzpatrick TB. The presenhpy known fistrixuhion of furocoumarins (psoralens) in plants. J Invest Dermatol. 1962; 39:225-239.
74. Watemberg N, Urkin Y, Witztum A. Phytophotodermatitis due to figs. Cutis; Cutaneous Med Pract. 1991; 48:151-152.
75. Moller H. Phototoxicity of Dictamnus alba. Contact Dermatitis. 1978; 4: 264-269.
76. Coffman K, Boyce WT, Hansen RC. Phytophotodermatitis simulating child abuse. Am J Dis Child. 1985; 139:239-240.
77. Mill J, Wallis B, Cuttle L, Mott J, Oakley A, Kimble R. Phytophotodermatitis: case reports of children presenting with blistering after preparing lime juice. Burns. 2008; 34:731-733.
78. Swerdlin A, Berkowitz C, Craft N. Cutaneous signs of child abuse. J Am Acad Dermatol. 2007; 57:371-392.
79. Gross TP, Ratner L, de Rodriguez O, Farrell KP, Israel E. An outbreak of phototoxic dermatitis due to limes. Am J Epidemiol. 1987; 125:509-514.
80. Egan CL, Sterling G. Phytophotodermatitis: a visit to Margaritaville. Cutis; Cutaneous Med Pract. 1993; 51:41-42.
81. Finkelstein E, Afek U, Gross E, Aharoni N, Rosenberg L, Halevy S. An outbreak of phytophotodermatitis due to celery. Int J Dermatol. 1994; 33:116-118.
82. Lutchman L, Inyang V, Hodgkinson D. Phytophotodermatitis associated with parsnip picking. J Accid & Emerg Med. 1999; 16:453-454.
83. Wagner AM, Wu JJ, Hansen RC, Nigg HN, Beiere RC. Bullous phytophotodermatitis associated with high natural concentrations of furanocoumarins in limes. Am J Contact Dermatitis. 2002; 13:10-14.
84. Weber IC, Davis CP, Greeson DM. Phytophotodermatitis: the other "lime" disease. J Emerg Med. 1999; 17:235-237.
85. Cather JC, Macknet MR, Menter MA. Hyperpigmented macules and streaks. Proceedings (Baylor University Medical Center). 2000; 13:405-406.
86. Lovell CR. Plants and the Skin. New York: Blackwell Scientific Publications; 1993.
87. Pathak MA. Phytophotodermatitis. Clinics Dermatol. 1986; 4:102-121.
88. Hale AL, Meepagala KM, Oliva A, Aliotta G, Duke SO. Phytotoxins from the leaves of Ruta graveolens. J Agr Food Chem. 2004; 52:3345-3349.
89. Schempp CM, Winghofer B, Langheinrich M, Schopf E, Simon JC. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steadystate administration of Hypericum perforatum extract (St. John's Wort). Skin Pharmatol Appl Skin Physiol. 1999; 12:299-304.
90. Bent S, Ko R. Commonly used herbal medicines in the United States: a review. Am J Med. 2004; 116:478-485.
91. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Therapies Health Med. 2005; 11:42-49.
92. Huang KC. The pharmacology of Chinese herbs. Boca Raton, FL: CRC Press; 1999.
93. NTP. Chemical Information Review Document for Dong quai. Supporting Nomination for Toxicological Evaluation by the National Toxicology Program 2008. ntp.niehs.nih.gov/ntp/noms/support docs/dong quai090308.pdf.
94. Boiy A, Roelandts R, Van Den Oord J, De Witte PAM. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin. Brit J Dermatol. 2008; 158:360-369.
95. Schulz V. Safety of St. John's Wort extract compared to synthetic antidepressants. Phytomed. 2006; 13:199-204.
96. Traynor NJ, Beattie PE, Ibbotson SH, Moseley H, Ferguson J, Woods JA. Photogenotoxicity of hypericin in HaCaT keratinocytes: Implications for St. John's Wort supplements and high dose UVA-1 therapy. Toxicol Lett. 2005; 158: 220-224.
97. Inbaraj JJ, Kukielczak BM, Bilski P, Sandvik SL, Chignell CF. Photochemistry and photocytotoxicity of alkaloids from Goldenseal (Hydrastis canadensis L.) 1. Berberine. Chem Res Toxicol. 2001; 14:1529-1534.
98. Ashwood-Smith MJ. Possible cancer hazard associated with 5-methoxypsoralen in suntan preparations. BMJ. 1979; 2:1144.
99. Forlot P. Possible cancer hazard associated with 5-methoxypsoralen in suntan preparation. BMJ. 1980; 280:648.
100. Makki S, Treffel P, Humbert P, Agache P. High-performance liquid chromatographic determination of citropten and bergapten in suction blister fluid after solar product application in humans. J Chromatogr. 1991; 563:407-413.
101. Treffel P, Makki S, Faivre B, Humbert P, Blanc D, Agache P. Citropten and bergapten suction blister fluid concentrations after solar product application in man. Skin pharmacology: Official J Skin Pharmatol Soc. 1991; 4:100-108.
102. Berlanda J, Kiesslich T, Engelhardt V, Krammer B, Plaetzer K. Comparative in vitro study on the characteristics of different photosensitizers employed in PDT. J Photochem Photobiol B. 2010; 100:173-180.
103. IARC. Solar and ultraviolet radiation. Monographs on the Evaluation of Carcinogenic Risks to Humans. Int Agency Res Cancer. 1992; 55.
104. Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol. 1991; 54:659-659.
105. Kagan J. Organic photochemistry: principles and applications. London; San Diego: Academic Press; 1993:234.
106. Bohne C, Faulhaber K, Giese B, et al. Studies on the mechanism of the photoinduced DNA damage in the presence of acridizinium salts-involvement of singlet oxygen and an unusual source for hydroxyl radicals. J Am Chem Soc. 2005; 127: 76-85.
107. Cadet J, Douki T, Frelon S, Sauvaigo S, Pouget JP, Ravanat JL. Assessment of oxidative base damage to isolated and cellular DNA by HPLC-MS/MS measurement. Free Radical Biol Med. 2002; 33:441-449.
108. Hirakawa K, Suzuki H, Oikawa S, Kawanishi S. Sequence-specific DNA damage induced by ultraviolet A-irradiated folic acid via its photolysis product. Arch Biochem Biophys. 2003; 410:261-268.
109. Hirakawa K, Yoshida M, Oikawa S, Kawanishi S. Base oxidation at 5' site of GG sequence in double-stranded DNA induced by UVA in the presence of xanthone analogues: relationship between the DNA-damaging abilities of photosensitizers and their HOMO energies. Photochem Photobiol. 2003; 77:349-355.
110. Kawanishi S, Hiraku Y. Sequence-specific DNA damage induced by UVA radiation in the presence of endogenous and exogenous photosensitizers. Current Problems Dermatol. 2001; 29:74-82.
111. Ravanat JL, Di Mascio P, Martinez GR, Medeiros MH, Cadet J. Singlet oxygen induces oxidation of cellular DNA. J Biol Chem. 2000; 275:40601-40604.
112. Ravanat JL, Martinez GR, Medeiros MH, Di Mascio P, Cadet J. Mechanistic aspects of the oxidation of DNA constituents mediated by singlet molecular oxygen. Arch Biochem Biophy. 2004; 423:23-30.
113. Ravanat JL, Sauvaigo S, Caillat S, et al. Singlet oxygen-mediated damage to cellular DNA determined by the comet assay associated with DNA repair enzymes. Biol Chem. 2004; 385:17-20.
114. Ackroyd R, Kelty C, Brown N, Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol. 2001; 74:656-669.
115. Aust SD, Chignell CF, Bray TM, Kalyanaraman B, Mason RP. Free radicals in toxicology. Toxicol and Appl Pharm. 1993; 120:168-178.
116. Comporti M. Lipid peroxidation and cellular damage in toxic liver injury. Lab Invest. 1985; 53:599-623.
117. Harman D. Free radical involvement in aging. Drugs Aging. 1993; 3:60-80.
118. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health Part C. 2009; 27:120-139.
119. Arfsten DP, Schaeffer DJ, Mulveny DC. The effects of near ultraviolet radiation on the toxic effects of polycyclic aromatic hydrocarbons in animals and plants: a review. Ecotoxicol Environ Safety. 1996; 33:1-24.
120. Mukhtar H, DelTito BJ, Jr., Matgouranis PM, Das M, Asokan P, Bickers DR. Additive effects of ultraviolet B and crude coal tar on cutaneous carcinogen metabolism: possible relevance to the tumorigenicity of the Goeckerman regimen. J Invest Dermatol. 1986; 87:348-353.
121. Bunce NJ, Zhu J. Products from photochemical reactions of naphthalene in air. Polycl Arom Compd. 1995; 5:123-130.
122. Kochany J, Maguire RJ. Sunlight photodegradation of metolachlor in water. J Agr Food Chem. 1994; 42:406-412.
123. Lane DA, Tang H. Photochemical degradation of polycyclic aromatic compounds. I. Naphthalene. Polycycl Arom Compd. 1995; 5:131-138.
124. Mackay D, Shiu WY. Aqueous solubility of polynuclear aromatic hydrocarbons. J Chem Eng Data. 1977; 22:399-402.
125. Pagni RM, Sigman ME. The photochemistry of PAHs and PCBs in water and on solids. Berlin: Springer; 1999.
126. Payne JR, Phillips CR. Photochemistry of petroleum in water. Environ Sci Tech. 1985; 19:569-579.
127. Toyooka T, Ibuki Y. DNA damage induced by coexposure to PAHs and light. Environ Toxicol Pharm. 2007; 23:256-263.
128. Floyd RA, West M, Hensley K. Oxidative biochemical markers: clues to understanding aging in long-lived species. Exp Gerontol. 2001; 36:619-640.
129. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J MolMed. 1996; 74:297-312.
130. Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol. 1997; 10:485-494.
131. Gorelick NJ. Validation issues for the use of transgenic mouse mutation assays in risk assessment. Prog in Clin Biol Res. 1996; 395:81-108.
132. Mori M, Kobayashi H, Katsumura Y, Furihata C. Induction of unscheduled DNA synthesis in hairless mouse epidermis by 8-methoxypsoralen plus ultraviolet A (PUVA). J Toxicol Sci. 2001; 26:1-8.
133. Bulera SJ, Theiss JC, Festerling TA, de la Iglesia FA. In vitro photogenotoxic activity of clinafloxacin: a paradigm predicting photocarcinogenicity. Toxicol Appl Pharmacol. 1999; 156:222-230.
134. Nishikawa T, Haresaku M, Adachi K, Masuda M, Hayashi M. Study of a rat skin in vivo micronucleus test: data generated by mitomycin C and methyl methanesulfonate. Mutat Res. 1999; 444:159-166.
135. Nishikawa T, Haresaku M, Fukushima A, et al. Further evaluation of an in vivo micronucleus test on rat and mouse skin: results with five skin carcinogens. Mutat Res. 2002; 513:93-102.
136. Nishikawa T, Nakamura T, Fukushima A, Takagi Y. Further evaluation of the skin micronucleus test: results obtained using 10 polycyclic aromatic hydrocarbons. Mutat Res. 2005; 588:58-63.
137. Bourgaud F, Hehn A, Larbat R, et al. Biosynthesis of coumarins in plants: a major pathway still to be unravelled for cytochrome P450 enzymes. Phytochem Revs. 2006; 5:293-308.
138. Wagstaff DJ. Dietary exposure to furocoumarins. Reg Toxicol Pharm. 1991; 14:261-272.
139. Tassaneeyakul W, Guo LQ, Fukuda K, Ohta T, Yamazoe Y. Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch Biochem Biophys. 2000; 378:356-363.
140. Goskowicz MO, Friedlander SF, Eichenfield LF. Endemic "lime" disease: phytophotodermatitis in San Diego County. Pediatrics. 1994; 93:828-830.
141. Nigg HN, Nordby HE, Beier RC, Dillman A, Macias C, Hansen RC. Phototoxic coumarins in limes. Food Chem Toxicol. 1993; 31:331-335.
142. Feskanich D, Willett WC, Hunter DJ, Colditz GA. Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women. Br J Cancer. 2003; 88:1381-1387.
143. Edwards DJ, Bellevue FH, Woster PM. Identification of 6-, 7-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Disp. 1996; 24:1287-1290.
144. Fukuda K, Ohta T, Oshima Y, Ohashi N, Yoshikawa M, Yamazoe Y. Specific CYP3 A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogen Genom. 1997; 7:391-396.
145. He K, Iyer KR, Hayes RN, Sinz MW,Woolf TF, Hollenberg PF. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol. 1998; 11:252-259.
146. Manthey JA, Buslig BlS. Distribution of furanocoumarins in grapefruit juice fractions. J Agr Food Chem. 2005; 53:5158-5163.
147. Messer A, Nieborowski A, Strasser C, Lohr C, Schrenk D. Major furocoumarins in grapefruit juice I: Levels and urinary metabolite (s). Food Chem Toxicol. 2011; 49:3224-3231.
148. Mohri K, Uesawa Y. Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharmaceut Res. 2001; 18:177-182.
149. Uesawa Y, Mohri K. The use of heat treatment to eliminate drug interactions due to grapefruit juice. Biol Pharmaceut Bullet. 2006; 29:2274-2278.
150. COT. Committees on toxicity, mutagenicity, carcinogenicity of chemicals in food, consumer products and the environment: 1996 annual report. Department of Health, HMSO publications; 1996.
151. SKLM. Update on the toxicological assessment of furanocoumarins in foodstuffs. DFG Senate Commission on Food Safety, Kaiserslautern, Germany 2010. http://www.dfg.de/download/pdf/dfg im profil/reden stellungnahmen/2010/sklm aktualisierung furocumarine 100125 en.pdf.
152. Guo L-Q, Yamazoe Y. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharm Sinica. 2004; 25:129-136.
153. Beier RC. Natural pesticides and bioactive components in foods. Reviews of Environmental Contamination and Toxicology.Ware, GR, editor. Springer-Verlag, New York. 1990; 113:47-137.
154. Kanerva L, Elsner P, Wahlberg J, Maibach H. Condensed Handbook of Occupational Dermatology. New York: Springer; 2004.
155. Berkley SF, Hightower AW, Beier RC, et al. Dermatitis in grocery workers associated with high natural concentrations of furanocoumarins in celery. Annal Intern Med. 1986; 105:351-355.
156. Birmingham DJ, Key MM, Tubich GE, Perone VB. Phototoxic bullae among celery harvesters. Arch Dermatol. 1961; 83:73-87.
157. Henry SA. Celery itch: dermatitis due to celery in vegetable canning. Br J Dermatol. 1933; 45:301-309.
158. Ivie GW, Holt DL, Ivey MC. Natural toxicants in human foods: Psoralens in raw and cooked parsnip root. Science. 1981; 213:909-910.
159. Ljunggren B. Severe phototoxic burn following celery ingestion. Arch Dermatol. 1990; 126:1334-1336.
160. Seligman PJ, Mathias CG, O'Malley MA, et al. Phytophotodermatitis from celery among grocery store workers. Arch Dermatol. 1987; 123:1478-1482.
161. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B: Biology. 1997; 39:1-18.
162. Buytaert E, Matroule JY, Durinck S, et al. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene. 2007; 27:1916-1929.
163. IARC. Monographs on the evaluation of carcinogenic risk to humans. Supplement 7: Overall evaluation of carcinogenicity: an updating of IARC monographs Vol. 1-42. International Agency for Research on Cancer. Lyon, France; 1987.
164. Katz KA, Marcil I, Stern RS. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet A Lighttreated psoriasis patients. J Invest Dermatol. 2002; 118:1038-1043.
165. Stern RS. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol. 2001; 44:755-761.
166. Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol. 1988; 91:120-124.
167. IARC. Some naturally occurring and synthetic food components, furocoumarins and ultraviolet radiation. International Agency for Research on Cancerm Monograph on the Evaluation of the Carcinogenic Risk of Chemicals for Humans; 1986; 40: 1-415.
168. Gruenert DC, Ashwood-Smith M, Mitchell RH, Cleaver JE. Induction of DNADNA cross-link formation in human cells by various psoralen derivatives. Cancer Res. 1985; 45:5394-5398.
169. Laquerbe A, Moustacchi E, Papadopoulo D. Genotoxic potential of psoralen cross-links versus monoadducts in normal human lymphoblasts. Mutat Res Lett. 1995; 346:173-179.
170. Loveday KS, Donahue BA. Induction of sister chromatid exchanges and gene mutations in Chinese hamster ovary cells by psoralens. Natl Cancer Inst Monograph. 1984; 66:149-155.
171. Uwaifo AO, Billings PC, Heidelberger C. Mutation of Chinese hamster V79 cells and transformation and mutation of mouse fibroblast C3H/10TA 12 clone 8 cells by aflatoxin B1 and four other furocoumarins isolated from two Nigerian medicinal plants. Cancer Res. 1983; 43:1054-1058.
172. Fulton JR, Willis I. Photoallergy to methoxsalen. Arch Derm. 1968; 98:445-450.
173. Plewig G, Hoffman C, Braun-Falco O. Photoallergic dermatitis from 8-methoxypsoralen. Arch Dermatol Res. 1983; 261:201-211.
174. Cartwright LE,Walter JF. Psoralen-containing sunscreen is tumorigenic in hairless mice. J Am Acad Dermatol. 1983; 8:830-836.
175. Young AR, Magnus IA, Davies AC, Smith NP. A comparison of the phototumorigenic potential of 8-MOP and 5-MOP in hairless albino mice exposed to solar simulated radiation. Br J Dermatol. 1983; 108:507-518.
176. Zajdela F, Bisagni E. 5-Methoxypsoralen, the melanogenic additive in sun-tan preparations, is tumorigenic in mice exposed to 365 nm UV radiation. Carcinogenesis. 1981; 2:121-127.
177. Averbeck D. Relationship between lesions photoinduced by mono-and bifunctional furocoumarins in DNA and genotoxic effects in diploid yeast. Mutat Res-Fund Mol M. 1985; 151:217-233.
178. Ashwood-Smith MJ, Poulton GA, Barker M, Mildenberger M. 5-Methoxypsor alen, an ingredient in several suntan preparations, has lethal, mutagenic and clastogenic properties. Nature. 1980; 285:407-409.
179. Pool BL, Deutsch-Wenzel RP. Evidence of the mutagenic effect of 5-methoxypsor alen (bergapten). Arztl Kosmetol. 1979; 9:349-355.
180. Abel G, Schimmer O. Mutagenicity and toxicity of furocoumarins: comparative investigations in 2 test systems. Mutat Res/Genet Toxicol. 1981; 90:451-461.
181. Gorgus E, Lohr C, Raquet N, Guth S, Schrenk D. Limettin and furocoumarins in beverages containing citrus juices or extracts. Food Chem Toxicol. 2010; 48:93-98.
182. Lohr C, Raquet N, Schrenk D. Application of the concept of relative photomutagenic potencies to selected furocoumarins in V79 cells. Toxicol Vitro. 2010; 24:558-566.
183. Raquet N, Schrenk D. Relative photomutagenicity of furocoumarins and limettin in the hypoxanthine phosphoribosyl transferase assay in V79 cells. Chem Res Toxicol. 2009; 22:1639-1647.
184. Ojala T, Vuorela P, Kiviranta J, Vuorela H, Hiltunen R. A bioassay using Artemia salina for detecting phototoxicity of plant coumarins. Planta Med. 1999; 65: 715-718.
185. Schlatter J. Die toxikologische bedeutung von furocoumarinen in pflanzlichen Lebensmitteln. Mitt Lebensmittelunters Hyg. 1988; 79:130-143.
186. IARC. IARC Monographs on the evaluation of the carcinogenic risks of chemicals to humans, allyl compounds, aldehydes, epoxides and peroxides. International Agency for Research on Cancer Lyon, France; 1985:32-33, 69-74.
187. Stern RS, Liebman EJ, Väkevä L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. J Nat Cancer Institute. 1998; 90:1278-1284.
188. Guth S, Habermeyer M, Schrenk D, Eisenbrand G. Update of the toxicological assessment of furanocoumarins in foodstuffs (Update of the SKLM statement of 23/24 September 2004). Mol Nutr Food Res. 2011; 55:807-810.
189. Stern RS, Bagheri S, Nichols K. REPORTS-The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol. 2002; 47:33-38.
190. Ramaswamy S. Psoralens in foods. Ind Food Packer. 1975; 8:37-46.
191. Grossweiner LI. Mechanisms of photosensitization by furocoumarins. Nat Can Inst Monographs. 1984; 66:47-54.
192. Dall'Aqua F. New chemical aspects of the photoreaction between psoralen and DNA. New York: Plenum; 1977.
193. Joshi PC, Pathak MA. Production of singlet oxygen and superoxide radicals by psoralens and their biological significance. Biochem Biophys Res Commun. 1983; 112:638-646.
194. Berenbaum MR, Nitao JK, Zangerl AR. Adaptive significance of furanocoumarin diversity in Pastinaca sativa (Apiaceae). J Chem Ecol. 1991; 17:207-215.
195. Midden WR. Chemical mechanisms of the bioeffects of furocoumarins: the role of reactions with proteins, lipids, and other cellular constituents. Boca Raton, FL: CRC Press; 1988.
196. Clark SM, Wilkinson SM. Phototoxic contact dermatitis from 5-methoxypsoralen in aromatherapy oil. Contact Dermatitis. 1998; 38:289-290.
197. Barnes J, Anderson LA, Phillipson JD. St John's Wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2001; 53:583-600.
198. Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St John's Wort in major depression. J Am Med Assoc. 2001; 285:1978-1986.
199. Kasper S. Pharmacological treatment of seasonal affective disorder-the role of hypericum extract. Psychopharmakotherapie. 1998; 5:21-25.
200. Vitiello B. Hypericum perforatum extracts as potential antidepressants.J Pharm Pharmacol. 1999; 51:513-517.
201. Giese AC. Hypericism. Photochem Photobiol Rev. 1980; 5:229-255.
202. Vanhaelen M, Vanhaelen-Fastre R. Quantitative determination of biologically active constituents in medicinal plant crude extracts by thin-layer chromatographydensitometry: I. Aesculus hippocastaneum L., Arctostaphyllos uva-ursi Spreng, Fraxinus excelsior L., Gentiana lutea L., Glycyrrhiza glabra L., Hamamelis virginiana L., Hypericum perforatum L., Olea europea L., Salix alba L. and Silybum marianum Gaertn. J Chromatogr A. 1983; 281:263-271.
203. Ali SM, Olivo M. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells. Int J Oncology. 2002; 21: 531-540.
204. Davids LM, Kleemann B, KacerovskA D, Pizinger K, Kidson SH. Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells. J Photochem Photobiol B: Biology. 2008; 91:67-76.
205. Galanou MC, Theodossiou TA, Tsiourvas D, Sideratou Z, Paleos CM. Interactive transport, subcellular relocation and enhanced phototoxicity of hypericin encapsulated in guanidinylated liposomes via molecular recognition. Photochem Photobiol. 2008; 84:1073-1083.
206. Buytaert E, Callewaert G, Hendrickx N, et al. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J. 2006; 20: 756-758.
207. Ritz R, Roser F, Radomski N, Strauss WS, Tatagiba M, Gharabaghi A. Subcellular colocalization of hypericin with respect to endoplasmic reticulum and Golgi apparatus in glioblastoma cells. Anticancer Res. 2008; 28:2033-2038.
208. Siboni G, Weitman H, Freeman D, Mazur Y, Malik Z, Ehrenberg B. The correlation between hydrophilicity of hypericins and helianthrone: internalization mechanisms, subcellular distribution and photodynamic action in colon carcinoma cells. Photochem Photobiol Sci. 2002; 1:483-491.
209. Uzdensky AB, Ma LW, Iani V, Hjortland GO, Steen HB, Moan J. Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines. Lasers Med Sci. 2001; 16:276-283.
210. Theodossiou T, SpiroMD, Jacobson J, Hothersall JS,MacRobert AJ. Evidence for intracellular aggregation of hypericin and the impact on its photocytotoxicity in PAM 212 murine keratinocytes. Photochem Photobiol. 2004; 80:438-443.
211. Thomas C, MacGill RS, Miller GC, Pardini RS. Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. Photochem Photobiol. 1992; 55:47-53.
212. Theodossiou TA, Hothersall JS, De Witte PA, Pantos A, Agostinis P. The multifaceted photocytotoxic profile of hypericin. Mol Pharm. 2009; 6:1775-1789.
213. Diwu Z, Lown JW. Photosensitization with anticancer agents. 17. EPR studies of photodynamic action of hypericin: Formation of semiquinone radical and activated oxygen species on illumination. Free Rad Biol Med. 1993; 14:209.
214. Hadjur C, Richard MJ, Parat MO, Jardon P, Favier A. Photodynamic effects of hypericin on lipid peroxidation and antioxidant status in melanoma cells. Photochem Photobiol. 1996; 64:375-381.
215. Jardon P, Lazortchak N, Gautron R. Formation d'oxygene singulet 1-g photosensibilisee par l'hypericine. Characterisation et etude du mechanisme par spectroscopie laser. J Chim Phys. 1987; 84:1141-1145.
216. Racinet H, Jardon P, Gautron R. Formation d'oxygene singulet 1-g photosensibilisee par l'hypericine. Etude cinetique en millieu micellaire non ionique. J Chim Phys. 1988; 85:971-977.
217. Miccoli L, Beurdeley-Thomas A, De Pinieux G, et al. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res. 1998; 58:5777-5786.
218. Rahimipour S, Palivan C, Barbosa FDR, et al. Chemical and photochemical electron transfer of new helianthrone derivatives: aspects of their photodynamic activity. J Am Chem Soc. 2003; 125:1376-1384.
219. Rahimipour S, Palivan C, Freeman D, et al. Hypericin derivatives: substituent effects on radical anion formation. Photochem Photobiol. 2001; 74:149-156.
220. Theodossiou TA, Noronha-Dutra A, Hothersall JS. Mitochondria are a primary target of hypericin phototoxicity: synergy of intracellular calcium mobilisation in cell killing. Int J Biochem Cell Biol. 2006; 38:1946-1956.
221. Macrobert AJ, Theodossiou T. Photodynamic Therapy of Cancer. Amsterdam: Elsevier; 2005.
222. Wilhelm KP, Biel S, Siegers CP. Role of flavonoids in controlling the phototoxicity of Hypericum perforatum extracts. Phytomed. 2004; 8:306-309.
223. Harris MS, Sakamoto T, Kimura H, et al. Hypericin inhibits cell growth and induces apoptosis in retinal pigment epithelial cells: possible involvement of protein kinase C. Current Eye Res. 1996; 15:255-262.
224. He YY, Chignell CF, Miller DS, Andley UP, Roberts JE. Phototoxicity in human lens epithelial cells promoted by St. John's Wort. Photochem Photobiol. 2004; 80:583-586.
225. Roberts JE, Remé CE, Dillon J, Terman M. Exposure to bright light and the concurrent use of photosensitizing drugs. N Engl J Med. 1992; 326:1500-1501.
226. Kimura H, Harris MS, Sakamoto T, et al. Hypericin inhibits choroidal endothelial cell proliferation and cord formation in vitro. Current Eye Res. 1997; 16: 967-972.
227. Busch EM, Gorgels TGMF, Roberts JE, Norren D. The effects of two stereoisomers of acetylcysteine on photochemical damage by UVA and blue light in rat retina. Photochem Photobiol. 1999; 70:353-358.
228. Hammond BR, Jr., Wooten BR, Max S. Density of the human crystalline lens is related to the macular pigment carotenoids, lutein and zeaxanthin. Optometry Vision Sci. 1997; 74:499-504.
229. Yeum K-J, Taylor A, Tang G, Russell RM. Measurement of carotenoids, retinoids, and tocopherols in human lenses. Invest Ophthalmol Visual Sci. 1995; 36: 2756-2761.
230. Mattocks AR. Chemistry and toxicology of pyrrolizidine alkaloids. London, NY: Academic Press; 1986.
231. Roeder E. Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazie. 1995; 50:83-98.
232. Roeder E. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie. 2000; 55:711-726.
233. Fu PP, Yang Y-C, Xia Q, Chou MW, Cui YY, Lin G. Pyrrolizidine alkaloidstumorigenic components in Chinese herbal medicines and dietary supplements. J Food Drug Analysis. 2002; 10:198-211.
234. IPCS. Pyrrolizidine Alkaloids Health and Safety Guides. Health and Safety Criteria Guides 26. International Programme on Chemical Safety. Geneva, Switzerland: World Health Organization; 1989.
235. Smith LW, Culvenor CC. Plant sources of hepatotoxic pyrrolizidine alkaloids. J Nat Prod. 1981; 44:129-152.
236. Zhao Y, Xia Q, da Costa GA, Yu H, Cai L, Fu PP. Full structure assignments of pyrrolizidine alkaloid DNA adducts and mechanism of tumor initiation. Chem Res Toxicol. 2012; 25:1985-1996.
237. Chou MW, Wang Y-P, Yan J, et al. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine. Toxicol Lett. 2003; 145:239-247.
238. Mattocks AR, Cabral JR. Carcinogenicity of some pyrrolic pyrrolizidine alkaloid metabolites and analogues. Cancer Lett. 1982; 17:61-66.
239. Rao MS, Reddy JK. Malignant neoplasms in rats fed lasiocarpine. Br J Cancer. 1978; 37:289.
240. Knight AP, Walter RG. Plants Affecting the Skin and Liver. Jackson, WY: Teton New Media; 2003.
241. Knight AP, Walter RG. A guide to plant poisoning of animals in North America. Jackson, WY: Teton New Media; 2001.
242. Clare NT. Photosensitization in animals. Adv Vet Sci. 1955; 2:182-211.
243. Foster S. Goldenseal's future. 2000. http://wwwstevenfostercom/education/ monog raph/goldensealhtml.
244. Blumenthal M. Herb market levels after five years of boom: 1999 sales in mainstream market up only 11% in first half of 1999 after 55% increase in 1998. Herbal Gram. 1999; 47:64-65.
245. Inbaraj JJ, Kukielczak BM, Bilski P, He YY, Sik RH, Chignell CF. Photochemistry and photocytotoxicity of alkaloids from Goldenseal (Hydrastis canadensis L.). 2. Palmatine, hydrastine, canadine, and hydrastinine. Chem Res Toxicol. 2006; 19:739-744.
246. Harmon NW. Goldenseal. Can Pharm J. 1990; 123:508-510.
247. Abidi P, Chen W, Kraemer FB, Li H, Liu J. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms. J Lipid Res. 2006; 47:2134-2147.
248. Dunnick JK, Singh B, Nyska A, Peckham J, Kissling GE, Sanders JM. Investigating the potential for toxicity from long-term use of the herbal products, goldenseal and milk thistle. Toxicol Pathol. 2011; 39:398-409.
249. Etheridge AS, Black SR, Patel PR, So J, Mathews JM. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Medica. 2007; 73:731-741.
250. Kulkarni SK, Dhir A. Current investigational drugs for major depression. Expert Opinion Invest Drugs. 2009; 18:768-788.
251. Palanisamy A, Haller C, Olson KR. Photosensitivity reaction in a woman using an herbal supplement containing ginseng, goldenseal, and bee pollen. Clin Toxicol. 2003; 41:865-867.
252. Abourashed EA, Khan IA. High performance liquid chromatography determination of hydrastine and berberine in dietary supplements containing goldenseal. J Pharmaceut Sci. 2001; 90:817-822.
253. TheMerck Index, 12th ed., Budarari, S, Ed.Merck Research Laboratories,Merck & Co., Inc., Whitehouse Station, NJ, 1996.
254. Dawes ML, Brettell T. Analysis of goldenseal, Hydrastis canadensis L., and related alkaloids in urine using HPLC with UV detection. J Chromatogr B. 2012; 880:114-118.
255. Douglas JA, Follett JM, Parmenter GA, Sansom CE, Perry NB, Littler RA. Seasonal variation of biomass and bioactive alkaloid content of goldenseal, Hydrastis Canadensis. Fitoterapia. 2010; 81:925-928.
256. Boberek JM, Stach J, Good L. Genetic evidence for inhibition of bacterial division protein FtsZ by berberine. PloS One. 2010; 5:e13745.
257. Ettefagh KA, Burns JT, Junio HA, Kaatz GW, Cech NB. Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition. Planta Medica. 2011; 77:835-840.
258. Hui H, Tang G, Go VLW. Hypoglycemic herbs and their action mechanisms. Chinese Med. 2009; 4:11.
259. Kulkarni SK, Dhir A. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytotherapy Res. 2010; 24:317-324.
260. Vuddanda PR, Chakraborty S, Singh S. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opinion Invest Drugs. 2010; 19:1297-1307.
261. Maiti M, Kumar GS. Molecular aspects on the interaction of protoberberine, benzophenanthridine, and aristolochia group of alkaloids with nucleic acid structures and biological perspectives. Med Res Rev. 2007; 27:649-695.
262. Serafim TL, Oliveira PJ, Sardao VA, Perkins E, Parke D, Holy J. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemotherapy Pharm. 2008; 61:1007-1018.
263. Letas?iová S, Jantová S, C? ipák L,Mú c?ková M. Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett. 2006; 239:254-262.
264. Leta?siová S, Jantová S, Ḿu?cková M, Theiszová M. Antiproliferative activity of berberine in vitro and in vivo. Biomed PapMed Fac Univ Palacky Olomouc Czech Repub. 2005; 149:461-463.
265. Shirwaikar A, Shirwaikar A, Rajendran K, Punitha ISR. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol Pharmaceut Bull. 2006; 29:1906-1910.
266. Chignell CF, Sik RH, Watson MA, Wielgus AR. Photochemistry and photocytotoxicity of alkaloids from Goldenseal (Hydrastis canadensis L.) 3: Effect on human lens and retinal pigment epithelial cells. Photochem Photobiol. 2007; 83:938-943.
267. Hamrapurkar PD, Lalla JK, Khandke SY. Quality Assessment of marketed Ayurvedic eye-drop preparation. Indian Drugs. 2000; 37:335-342.
268. Babbar OP, Chhatwal VK, Ray IB, Mehra MK. Effect of berberine chloride eye drops on clinically positive trachoma patients. Ind J Med Res. 1982; 76:83-88.
269. Khosla PK, Neeraj VI, Gupta SK, Satpathy G. Berberine, a potential drug for trachoma. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique. 1992; 69:147.
270. NTP. NTP technical report on toxicology and carcinogenesis studies of kava extract in F344/N rats and B6C3F1 mice. NTP TR 571, NIH Publication No11-5913 2011.
271. Wooltorton E. Herbal kava: reports of liver toxicity. Can Med Assoc J. 2002; 166:777-777.
272. Norton SA. Herbal medicines in Hawaii from tradition to convention. Hawaii Med J. 1998; 57:382-386.
273. Norton SA, Ruze P. Kava dermopathy. J Am Acad Derm. 1994; 31:89-97.
274. Ruze P. Kava-induced dermopathy: a niacin deficiency? Lancet. 1990; 335: 1442-1445.
275. Andersen FA. Final report on the safety assessment of azulene. Int J Toxicol. 1999; 18:27-32.
276. Guarrera M, Turbino L, Rebora A. The anti-inflammatory activity of azulene. J Eur Acad Dermatol Venereology. 2001; 15:486-487.
277. Kourounakis AP, Rekka EA, Kourounakis PN. Antioxidant activity of guaiazulene and protection against paracetamol hepatotoxicity in rats. J Pharm Harm. 1997; 49:938-942.
278. Yanagisawa T, Kosakai K, Tomiyama T, Yasunami M, Takase K. Studies on antiulcer agents. II. Synthesis and anti-ulcer activities of 6-isopropylazulene-1-sodium sulfonate derivatives. Chem Pharm Bull. 1990; 38:3355-3358.
279. Fiori J, Gotti R, Albini A, Cavrini V. Study on the photostability of guaiazulene by high performance liquid chromatography/mass spectrometry and gas chromatography/mass spectrometry. Rapid Comm Mass Spect. 2008; 22:2698-2706.
280. Selco JI, Brooks T, Chang M, Trieu MT, McDonald JK, McManus SP. Solution photochemistry of azulene. J Org Chem. 1994; 59:429-433.
281. Parekh KA, Yu H. Light-induced damages by cosmetic and skin care products. J Miss Acad Sci. 2002; 47.
282. Koster G, Martin JML, Lifshitz C. Robert Squires Memorial Articles-energetics of the naphthalene/azulene monocation isomerization: density functional and coupled cluster calculations. J Chem Soc-Perkin Transactions II. 1999:2383-2388.
283. Tetreault N,Muthyala RS, Liu RSH, Steer RP. Control of the photophysical properties of polyatomic molecules by substitution and solvation: the second excited singlet state of azulene. J Phys Chem A. 1999; 103:2524-2531.
284. Kraljic I, El Mohsni S. A new method for the detection of singlet oxygen in aqueous solutions. Photochem Photobiol. 1982; 28:577-581.
285. Struwe M, Csato M, Singer T, Gocke E. Comprehensive assessment of the photomutagenicity, photogenotoxicity and photo (cyto) toxicity of azulene. Mutat Res-Gen Tox En. 2011; 723:129-133.
286. Franchi E, Ingrosso G, Marchetti F, Pinzino C. Guaiazulene-based phenolic radical scavengers: synthesis, properties, and EPR studies of their reaction with oxygencentred radicals. Tetrahedron. 2003; 59:5003-5018.
287. Rekka E, Chrysselis M, Siskou I, Kourounakis A. Synthesis of new azulene derivatives and study of their effect on lipid peroxidation and lipoxygenase activity. Chem Pharm Bull. 2002; 50:904-907.
288. Lion Y, Delmelle M, Van de Vorst A. New method of detecting singlet oxygen production. Nature. 1976; 263:442-443.
289. Lion Y, Gandin E, Vorst A. On the production of nitroxide radicals by singlet oxygen reaction: an EPR study. Photochem Photobiol. 1980; 31:305-309.
290. Noda Y, Kohno M, Mori A, Packer L. Automated electron spin resonance free radical detector assays for antioxidant activity in natural extracts. Meth Enzymol. 1999; 299:28-34.